Latest Breaking News On - Rob etherington - Page 3 : comparemela.com

FDA unconvinced by Clene s request for accelerated approval tag

FDA unconvinced by Clene s request for accelerated approval tag
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Benjamin greenbergRob etheringtonNational institutes of healthSalt lake city basedNational institutesMedical benjamin greenberg

As ALS research booms, one treatment center finds itself in the spotlight

BioPharma

United statesUniversity of washington medical centerSabrina paganoniJackie whitesellMichael weissMichael haydenClene nanomedicineJen scaliaJosh cohenRob etheringtonJustin kleeJeremy shefnerSeanm healeyRudy tanziJoe bidenAmylyx cohen

Clene Reports Third Quarter 2023 Financial Results and Operating Highlights

Clene Reports Third Quarter 2023 Financial Results and Operating Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNational institutes of healthSalt lake cityClene nanomedicineRob etheringtonIgnacio guerrero rosSecurities exchangeClene incClene nanomedicine incNational institute of neurological disordersDrug administrationColumbia universityDavid schullrusso partnersCleneclene incRecent operatingNational institute

Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference

Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSalt lake cityDavid schullKevin gardnerMorgan brownIgnacio guerrero rosRob etheringtonIntercontinental barclay hotelClene nanomedicine incClene incRusso partnersCantor fitzgerald annual global healthcareChief executive officerChief financial officerClene nanomedicine

Clene to Present at the Canaccord Genuity 43rd Annual Growth Conference

SALT LAKE CITY, Aug. 02, 2023 (GLOBE NEWSWIRE) Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases, today announced that it will present at the Canaccord Genuity 43rd Annual Growth Conference. Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, will participate in the presentatio

United statesSalt lake cityCanaccord genuityMorgan brownRob etheringtonIntercontinental hotelClene nanomedicine incClene incAnnual growthChief executive officerChief financial officerClene incNeurodegenerative diseasesIopharmaceutical companyMorgan brownLene nanomedicine inc